Nevro Corp (NYSE:NVRO)
$ 4.58 0.26 (6.02%) Market Cap: 171.62 Mil Enterprise Value: 141.17 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 43/100

Nevro Corp at Bank of America Global Healthcare Conference Transcript

May 11, 2023 / 12:00AM GMT
Release Date Price: $27.11 (-3.01%)
Operator

I'm Travis Steed, Medical Device Analyst at Bank of America. And up next, we have Nevro Corporation. We've got Kevin Thornal, Chief Executive Officer, first time at a conference, so thank you for coming. And got Rod, CFO; and of course, Julie Dewey as well. Thanks for coming. I hope, my mic is on. I'm sure.

Okay. So maybe, Keith, just...

Kevin R. Thornal
Nevro Corp. - President, CEO & Director

Kevin.

Julie D. Dewey
Nevro Corp. - Chief Corporate Communications & IR Officer

I swear.

Travis Lee Steed
BofA Securities, Research Division - MD

The previous CEO was Keith, I see that, sorry. So I was just reading, sorry about that Kevin.

Julie D. Dewey
Nevro Corp. - Chief Corporate Communications & IR Officer

Those of you who know me, it was like that. I said, no, no, no. Here's his name.

Kevin R. Thornal
Nevro Corp. - President, CEO & Director

It's all right.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot